Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Weight-loss drugmakers report strong earnings: Boon or bane?
Views 123K Contents 246

Stock Markets Rocked as Weight Loss Sweeps the Globe

Weight loss drugs lead the stock market
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S (NVO.US)$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $Eli Lilly and Co (LLY.US)$ , which makes the GLP-1 drug Mounjaro, is now the ninth-largest company in the S&P 500 with a market capitalization of $568 billion.
Stock Markets Rocked as Weight Loss Sweeps the Globe
How big is this market? According to the latest estimates, U.S. healthcare spending in 2022 totaled $4.4 trillion.
The "miracle cure-all" effect, some people are happy and some people are sad
Originally as a treatment of diabetes drugs GLP-1 drugs not only in the field of weight loss God, heart disease, kidney disease, dementia, tobacco and alcohol addiction and other issues can also play an effective role, so the outside world as a "panacea".
There is no doubt that GLP-1 will have an impact on the original enterprises in these tracks.
For example, on Tuesday, Novo Nordisk announced the results of a drug trial showed that Semaglutide (Semaglutide, the active ingredient in the type 2 diabetes drug Ozempic and the "miracle weight-loss drug" Wegovy) may be very helpful in treating kidney failure in diabetic patients.
On the day of the announcement, $DaVita (DVA.US)$ and $Fresenius Medical Care (FMS.US)$ , the world's largest kidney dialysis providers, both fell more than 10 percent. Meanwhile, shares of Novo Nordisk and Eli Lilly both jumped.
Stock Markets Rocked as Weight Loss Sweeps the Globe
Even insulin pump giants $Tandem Diabetes Care (TNDM.US)$ and $Insulet (PODD.US)$ have seen their shares fall the hardest, with cumulative year-to-date declines of 61% and 54%, respectively.
A Morgan Stanley survey of 300 patients using these diet pills showed a 20 to 30 percent reduction in their daily calorie intake. Retail giant Wal-Mart recently issued a warning that consumers who are taking Ozempic, Wegovy and other diet pills have seen a decrease in shopping demand.
The resulting negativity has dragged down shares of food retailers such as $Walmart (WMT.US)$ and $Costco (COST.US)$ , as well as food companies such as $Coca-Cola (KO.US)$ , $PepsiCo (PEP.US)$ and $McDonald's (MCD.US)$ .
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
+0
Translate
Report
230K Views
Comment
Sign in to post a comment